VDAC1P1

Across TCGA pan-cancer cohorts, VDAC1P1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated VDAC1P1 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher VDAC1P1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated VDAC1P1 expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

DLBC, BLCA, and UCEC are the cancer types where VDAC1P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Median	II,III,IV	0.118	0.802	.025	12	view →
BLCA	DFS	Median	All	0.096	0.626	<.001	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
LUAD	DFS	Median	II,III,IV	1.000	0.226	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

VDAC1P1–DLBC (OS)

Open the DLBC breakdown →